These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28673577)

  • 1. Cognitive impairment in diabetes and poor glucose utilization in the intracellular neural milieu.
    Contreras CM; Gutiérrez-García AG
    Med Hypotheses; 2017 Jul; 104():160-165. PubMed ID: 28673577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in cognitive function in patients with diabetes mellitus].
    Szémán B; Nagy G; Varga T; Veres-Székely A; Sasvári M; Fitala D; Szollosi A; Katonai R; Kotyuk E; Somogyi A
    Orv Hetil; 2012 Mar; 153(9):323-9. PubMed ID: 22348847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebral complications of diabetes mellitus].
    Aszalós Z
    Orv Hetil; 2007 Dec; 148(50):2371-6. PubMed ID: 18055361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Scylla and Charybdis of glucose control in childhood type 1 diabetes?
    McNeilly AD; McCrimmon RJ
    Pediatr Diabetes; 2015 Jun; 16(4):235-41. PubMed ID: 25727089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue and cognitive symptoms in patients with diabetes: relationship with disease phenotype and insulin treatment.
    Lasselin J; Layé S; Barreau JB; Rivet A; Dulucq MJ; Gin H; Capuron L
    Psychoneuroendocrinology; 2012 Sep; 37(9):1468-78. PubMed ID: 22370460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.
    Cox DJ; Kovatchev BP; Gonder-Frederick LA; Summers KH; McCall A; Grimm KJ; Clarke WL
    Diabetes Care; 2005 Jan; 28(1):71-7. PubMed ID: 15616236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study.
    Trento M; Charrier L; Salassa M; Merlo S; Passera P; Cavallo F; Porta M
    Acta Diabetol; 2015 Dec; 52(6):1157-66. PubMed ID: 26374233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing the gap between literature and practice: evaluation of a teaching programme (in the absence of a structured treatment) on both type 1 and type 2 diabetes.
    Matteucci E; Giampietro O
    Diabetes Nutr Metab; 2003; 16(5-6):298-305. PubMed ID: 15000441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, Depression, and Cognition: a Recursive Cycle of Cognitive Dysfunction and Glycemic Dysregulation.
    Black S; Kraemer K; Shah A; Simpson G; Scogin F; Smith A
    Curr Diab Rep; 2018 Sep; 18(11):118. PubMed ID: 30267224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
    Zaccardi F; Webb DR; Yates T; Davies MJ
    Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of reduced insulin-stimulated bone blood flow in the pathogenesis of metabolic insulin resistance and diabetic bone fragility.
    Hinton PS
    Med Hypotheses; 2016 Aug; 93():81-6. PubMed ID: 27372862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.
    Awad N; Gagnon M; Messier C
    J Clin Exp Neuropsychol; 2004 Nov; 26(8):1044-80. PubMed ID: 15590460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
    Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
    BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of iNOS alleviates cognitive deficits and depression in diabetic mice through downregulating the NO/sGC/cGMP/PKG signal pathway.
    Zhou XY; Zhang F; Ying CJ; Chen J; Chen L; Dong J; Shi Y; Tang M; Hu XT; Pan ZH; Xu NN; Zheng KY; Tang RX; Song YJ
    Behav Brain Res; 2017 Mar; 322(Pt A):70-82. PubMed ID: 28077315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.